Verizon Frontline challenges innovators to build future of public safety Vor Bio Prices Underwritten Offering of Common Stock and Concurrent Private Placement for Aggregate Proceeds of $115.8 Million
CAMBRIDGE, Mass., Dec. 07, 2022 (GLOBE NEWSWIRE) — Vor Bio (Nasdaq: VOR), a clinical-stage cell…
First AML Patient Successfully Transplanted with Vor Bio’s Investigational Trem-cel (VOR33) and Tolerated Mylotarg™
Trem-cel (formerly VOR33) successfully manufactured and engrafted normally Blood counts successfully maintained following post-transplant treatment…
Dante Genomics launches doctor ordered, clinical whole genome sequencing in the U.S. in partnership with 1health.io
– Dante Genomics uses the 1health.io platform to accelerate their go to market strategy and…
Atsena Therapeutics to Present at NewYorkBIO’s December 2022 Emerging Life Science Company Showcase
DURHAM, N.C., Dec. 07, 2022 (GLOBE NEWSWIRE) — Atsena Therapeutics, a clinical-stage gene therapy company…
HCW Biologics is Granted Second Fundamental Patent: U.S. Patent for Multi-Chain Chimeric Polypeptide Created with TOBI™ Platform
Allowed Claims for Novel Immunotherapeutic Compound Constructed with Tissue Factor as Platform for Target Binding Domains…
Cronos Unveils its New CBC Product: Spinach FEELZ™ Day Trip Gummies With THC+CBC
Spinach FEELZ™ THC+CBC Day Trip Gummies Spinach FEELZ™ THC+CBC Day Trip Gummies TORONTO, Dec. 07,…
Prometheus Biosciences Announces Positive Results for PRA023 in Both ARTEMIS-UC Phase 2 and APOLLO-CD Phase 2a Studies Enabling Pathway to Both First-in-Class and Best-in-Class Anti-TL1A mAb
– ARTEMIS-UC trial met primary endpoint with 26.5% of patients on PRA023 achieving clinical remission…
Replimune Announces Positive Initial Data from the Anti-PD1 Failed Melanoma Cohort of the IGNYTE Clinical Trial & an RP2/3 Program Update
RP1 combined with nivolumab continues to demonstrate deep and durable responses in patients with anti-PD1…
Bio-Path Holdings Announces First Patient Dosed in Phase 1/1b Clinical Trial of BP1001-A in Solid Tumors
Phase 1/1b Clinical Trial Evaluating Ability of BP1001-A to Treat Patients with Solid Tumors, Including…
Castellum, Inc. Announces Insider Open-Market Stock Purchases
Castellum, Inc. Announces Insider Open-Market Stock Purchases Castellum, Inc.’s (the “Company”) (NYSE-American: CTM), Mark C….
Replimune Enters into Clinical Collaboration Agreement with Roche for the Development of RP3 In Colorectal Cancer and Hepatocellular Carcinoma
RP3 will be developed in combination with atezolizumab and bevacizumab for the third-line treatment of…
Bazaarvoice Announces First-to-Market Revenue Attribution for Organic Facebook Posts
Tools will enable social media managers to track and optimize top performing posts to drive…
Coalesce Expands Leadership Team with Key Hires Across Departments
Data Transformations Startup Bolsters Team With Seasoned Hires Following Series A SAN FRANCISCO, Dec. 07,…
Fortinet Secure SD-WAN Delivers 300% ROI Over Three Years and Payback in Eight Months, New Independent Study Finds
Feedback from large enterprises with more than $1 billion in revenue and up to 8,500…
OSS Wins Multi-Million-Dollar AI Transportable Program with Leading 5G Cellular Provider
OSS Gen 4 PCIe® SDS-3U GPU-Accelerated Server OSS Gen 4 PCIe® SDS-3U GPU-Accelerated Server ESCONDIDO,…
Carbeeza Inc. Announces Maritimes Launch Date
CALGARY, Alberta, Dec. 07, 2022 (GLOBE NEWSWIRE) — Carbeeza Inc. (TSX.V: AUTO) (the “Company” or…
Wave Launches ‘Creator Economy Financial Playbook’ To Enable Entrepreneurial Success for the Fastest Growing Segment of Small Business
New playbook provides proven strategies and real-world advice to help creators turn their passions into…
MadeMarket Selects CapLinked as Virtual Data Room Solution
CapLinked has partnered with investment banking CRM provider MadeMarket to offer virtual data room capabilities…
Ehave Shareholder from CEO Ben Kaplan and Corporate Update
MIAMI, Dec. 07, 2022 (GLOBE NEWSWIRE) — Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a…
$62 Billion Potential Sex Toy Market Could be Disrupted by Israeli Cannabis Technology Company BYND Cannasoft Enterprises’ PCT Patent Application
PCT patent application could potentially cover the EZ-G device as a sex toy, as well…